Cancer Family
Osteogenic Neoplasm
CI-CAN-00000304Explore in graph →
Non-malignant101 active trials6 approved drugs8 evidence items
- NCIt
- C6603
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000304Explore in graph →
Clinical trials
357 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00686738 | Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients | completed | — | 20 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 23, 2016 | clinicaltrials |
| NCT01807143 | Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma | completed | — | 10 | Children's Oncology GroupNETWORK | 1 | Mar 8, 2016 | clinicaltrials |
| NCT00586846 | Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma | completed | Phase 2 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT01758666 | A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy | unknown | N/A | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Dec 22, 2015 | clinicaltrials |
| NCT01674101 | Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy | completed | N/A | 20 | St. Jude Children's Research HospitalOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT00743509 | A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma(OCR) | completed | Phase 2 | 49 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT02309242 | Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study | unknown | N/A | 60 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Aug 21, 2015 | clinicaltrials |
| NCT01016015 | Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma | completed | Phase 2 | 178 | National Cancer Institute (NCI)NIH | 2 | Jul 30, 2015 | clinicaltrials |
| NCT01804374 | Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma(SERIO) | completed | Phase 2 | 38 | Italian Sarcoma GroupNETWORK | 1 | Jun 17, 2015 | clinicaltrials |
| NCT02022358 | Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays? | terminated | Phase 2 | 34 | University College, LondonOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT01374672 | Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma | completed | — | 20 | Children's Oncology GroupNETWORK | 1 | May 12, 2015 | clinicaltrials |
| NCT02429973 | Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma(GEIS-29) | completed | Phase 2 | 33 | Broto, Javier Martín, M.D.INDIV | 0 | Apr 29, 2015 | clinicaltrials |
| NCT00030667 | Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00831844 | Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 3 | Mar 30, 2015 | clinicaltrials |
| NCT01518413 | Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors | completed | Phase 1 | 17 | HMeanyOTHER | 1 | Feb 27, 2015 | clinicaltrials |
| NCT00093080 | Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) | completed | Phase 2 | 216 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 13, 2015 | clinicaltrials |
| NCT02302651 | Non-invasive Focal Therapy for Osteoid Osteoma | unknown | Phase 2 / Phase 3 | 60 | University of Roma La SapienzaOTHER | 1 | Nov 27, 2014 | clinicaltrials |
| NCT00615329 | Huntsman Biopsy Study | terminated | — | 142 | State University of New York - Upstate Medical UniversityOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT00331643 | Ixabepilone in Treating Young Patients With Refractory Solid Tumors | completed | Phase 2 | 120 | National Cancer Institute (NCI)NIH | 1 | Nov 14, 2014 | clinicaltrials |
| NCT00503295 | Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung | completed | Phase 2 | 53 | Oncolytics BiotechINDUSTRY | 1 | Oct 2, 2014 | clinicaltrials |
| NCT00634322 | High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma | terminated | Phase 2 | 7 | BTG International Inc.OTHER | 0 | Sep 15, 2014 | clinicaltrials |
| NCT00673179 | Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy | terminated | N/A | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT01002092 | A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma | unknown | Phase 2 | 160 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Sep 3, 2014 | clinicaltrials |
| NCT00631631 | Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma | completed | — | 205 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | May 14, 2014 | clinicaltrials |
| NCT00330421 | Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2014 | clinicaltrials |
| NCT01491594 | Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia | terminated | Phase 1 | 1 | Duke UniversityOTHER | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01258634 | A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response | terminated | Phase 1 | 2 | University of ChicagoOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01216826 | Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma | unknown | Phase 2 | 20 | Sidnei EpelmanOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00012181 | Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01112800 | Markers of Anthracycline-Related Cardiac Muscle Injury | withdrawn | — | 0 | St. Jude Children's Research HospitalOTHER | 0 | Jun 19, 2013 | clinicaltrials |
| NCT00004078 | Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 2 | 181 | Children's Oncology GroupNETWORK | 1 | Jun 14, 2013 | clinicaltrials |
| NCT01492569 | Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting | withdrawn | N/A | 0 | Stanford UniversityOTHER | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00077454 | Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 95 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00093821 | Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors | completed | Phase 1 | 70 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00615628 | Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18: | terminated | — | 8 | State University of New York - Upstate Medical UniversityOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00889057 | Sorafenib in Relapsed High Grade Osteosarcoma | completed | Phase 2 | 35 | Italian Sarcoma GroupNETWORK | 1 | Mar 28, 2013 | clinicaltrials |
| NCT00004241 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00023998 | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Feb 4, 2013 | clinicaltrials |
| NCT01780779 | Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults(FUBEO) | unknown | — | 25 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00504140 | Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00132158 | ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 19 | St. Jude Children's Research HospitalOTHER | 1 | Apr 17, 2012 | clinicaltrials |
| NCT01466010 | Treatment Outcome After Surgical Treatment of Osteoid Osteoma | completed | — | 150 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Nov 7, 2011 | clinicaltrials |
| NCT00588510 | Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction | completed | — | 59 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00523419 | Chemotherapy for Patients With Osteosarcoma | completed | Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 28, 2011 | clinicaltrials |
| NCT00689195 | Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma(OSCAT) | unknown | Phase 1 / Phase 2 | 24 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00691236 | Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma(ZOL) | unknown | Phase 2 / Phase 3 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00145639 | Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma | completed | Phase 2 | 80 | St. Jude Children's Research HospitalOTHER | 2 | Jun 10, 2011 | clinicaltrials |
| NCT00572130 | Phase II Study of Intravenous Rexin-G in Osteosarcoma | completed | Phase 2 | 22 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Mar 23, 2016source: clinicaltrials